We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

Isarna Therapeutics Enters into a Strategic Manufacturing Agreement with Sanofi

Sanofi will manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for Isarna.

Avillion Group Partners with Pfizer

Agreement will see companies co-develop BOSULIF®(bosutinib) as first-line treatment for patients with chronic myelogenous leukemia.

TTP Labtech Acquires Assets from AssayMetrics

Significant improvements in assay reagents and availability of HTS-compatible readers has propelled fluorescence lifetime technology to the vanguard of cost-effective screening technologies.

Priaxon Appoints Dr Constance Hoefer as Chief Development Officer

Dr Hoefer will oversee the non-clinical and early clinical development.

Scientists Solve a Sticky Problem

Researchers have determined the 3-dimensional structure of SabA, a protein that cause gastric disease.

Foundation Medicine Extends and Expands Collaboration with Novartis

Collaboration will now extend through at least September 2016.

DySIS Medical Appoints Chairman

Robert Cascella joins as Chairman of the board of directors effective January 2014, further strengthening the board following a year of investment and growth in 2013.

Cell Medica Achieves EU Orphan Drug Designation

Orphan drug designation in the European Union for Cytovir ADV.

Adocia Launches Phase IIa Clinical Trial for its Ultra-fast Acting Formulation of Analog Insulin

The aim is to confirm on type I diabetic patients the positive results obtained during phase I.

Aratana Therapeutics Acquires Okapi Sciences NV

Adds to European presence and expands product portfolio.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter